Report on the Latin American Hematopoietic Stem Cell Transplantation in Inborn Errors of Immunity Group’s Activities: Bringing Us Together!

Introduction The Latin American Hematopoietic Stem Cell Transplantation (HSCT) in Inborn Errors of Immunity (IEIs) Group (GLATEII) was established at the 2023 Latin American Society for Immunodeficiencies (LASID) meeting in Mexico. Its goal is to unite Latin American immunologists and transplant specialists. We agreed to hold monthly meetings to discuss HSCT issues in IEIs, develop guidelines, and conduct multicenter reports on HSCT in IEIs. This report summarizes GLATEII’s activities. Results To date, GLATEII has held 19 online meetings, one each month. Since February 2024, these meetings have been hosted and recorded by LASID. A total of 12 recordings are available up to April 2025, with an average of 23 participants per meeting (range 12–30). Attendees mainly include pediatric and adult immunologists and transplant specialists, along with infectologists and hematologists. Participants represent 38 institutions across 11 countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Germany, Mexico, Paraguay, Peru, Uruguay, and the USA. Topics discussed include local experiences with HSCT for IEIs, case discussions, post-HSCT immune reconstitution, post-HSCT vaccination, and HSCT in specific IEIs. Regional concerns such as “transplante social,” Bacillus Calmette–Guérin vaccination issues, IEI awareness gaps, financial shortages for treatments or studies, and access disparities have also been addressed. GLATEII has conducted multicenter reports on specific IEIs, one of which will be presented at LASID 2025. Conclusion GLATEII has successfully maintained monthly meetings focused on HSCT in IEIs from a Latin American perspective, highlighting regional similarities and differences. These gatherings promote advances in diagnosis, treatment, and transplant techniques while strengthening regional and international networks of healthcare professionals. We invite all LASID members to expand and continue these valuable activities.

Authors

Institutions

Publication Details

Journal
Journal of Human Immunity
Published
2025-12-22
DOI
https://doi.org/10.70962/lasid2025abstract.4
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Report on the Latin American Hematopoietic Stem Cell Transplantation in Inborn Errors of Immunity Group’s Activities: Bringing Us Together!

Nideshda Ramírez-Uribe, Alfonso Ballesteros Fernández, Carmen S. Bonfim, Cristian Sotomayor et al.
Journal of Human Immunity
Immunodeficiency and Autoimmune Disorders
article

Report on the Latin American Hematopoietic Stem Cell Transplantation in Inborn Errors of Immunity Group’s Activities: Bringing Us Together!

Nideshda Ramírez-Uribe, Alfonso Ballesteros Fernández, Carmen S. Bonfim, Cristian Sotomayor, Alberto Alfaro
article en

Abstract

Introduction The Latin American Hematopoietic Stem Cell Transplantation (HSCT) in Inborn Errors of Immunity (IEIs) Group (GLATEII) was established at the 2023 Latin American Society for Immunodeficiencies (LASID) meeting in Mexico. Its goal is to unite Latin American immunologists and transplant specialists. We agreed to hold monthly meetings to discuss HSCT issues in IEIs, develop guidelines, and conduct multicenter reports on HSCT in IEIs. This report summarizes GLATEII’s activities. Results To date, GLATEII has held 19 online meetings, one each month. Since February 2024, these meetings have been hosted and recorded by LASID. A total of 12 recordings are available up to April 2025, with an average of 23 participants per meeting (range 12–30). Attendees mainly include pediatric and adult immunologists and transplant specialists, along with infectologists and hematologists. Participants represent 38 institutions across 11 countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Germany, Mexico, Paraguay, Peru, Uruguay, and the USA. Topics discussed include local experiences with HSCT for IEIs, case discussions, post-HSCT immune reconstitution, post-HSCT vaccination, and HSCT in specific IEIs. Regional concerns such as “transplante social,” Bacillus Calmette–Guérin vaccination issues, IEI awareness gaps, financial shortages for treatments or studies, and access disparities have also been addressed. GLATEII has conducted multicenter reports on specific IEIs, one of which will be presented at LASID 2025. Conclusion GLATEII has successfully maintained monthly meetings focused on HSCT in IEIs from a Latin American perspective, highlighting regional similarities and differences. These gatherings promote advances in diagnosis, treatment, and transplant techniques while strengthening regional and international networks of healthcare professionals. We invite all LASID members to expand and continue these valuable activities.

Journal of Human ImmunityVol. 1(LASID2025)
Pontificia Universidad Católica de Chile (CL), Duke University (US), Centro Universitário Franciscano do Paraná (BR), Facultad Latinoamericana de Ciencias Ecuador (EC), Hospital San Juan de Dios (CL), Instituto Nacional de Pediatria (MX)
Openalex Percentile: Top 37%
Immunodeficiency and Autoimmune Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.